Moneycontrol PRO

Outskill Genai

you are here: HomeNewsBusinessStocksAvoid Ranbaxy Laboratories: Sudarshan Sukhani

SHOW NAMES

Trending Topics

business

Avoid Ranbaxy Laboratories: Sudarshan Sukhani

One can avoid Ranbaxy Laboratories as it is showing no signs of stability, says Sudarshan Sukhani of s2analytics.com.

first published: Jun 18, 2013 02:04 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Nifty On Track To End Week Above 25,500 As Bank & Metal Stocks Lead Rebound| Closing Bell Live
Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live
Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live
Pine Labs’ Rs 3,900 Cr IPO| CEO Amrish Rau On Why The Issue Size Was Cut & The Post-IPO Gameplan

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347